Search for: "Apotex, Inc. " Results 81 - 100 of 674
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Jan 2018, 7:32 am by Lawrence B. Ebert
Apotex was vacated :In this Hatch-Waxman case, Apotex Inc. and ApotexCorp. appeal from the district court’s claim construction of“extended release coating” and its finding that Apotex’sproduct infringes U.S. [read post]
9 Nov 2017, 4:00 am by Alan Macek
In that decision (Apotex Inc. v. [read post]
25 Oct 2017, 6:55 am by Overhauser Law Offices, LLC
Other petitioners joined in the case are Apotex, Inc, Teva Pharmaceuticals USA, Fresenius Kabi USA, and Wockhardt Bio AG. [read post]
23 Jul 2017, 4:00 am by Administrator
Apotex Inc., 2017 SCC 36 (36654) The Promise Doctrine is not the correct approach to determine whether a patent has sufficient utility. [read post]
9 Jul 2017, 3:15 am by Barry Sookman
https://t.co/tXTvWuHCR3 -> Link to new copyright parody case, United Airlines, Inc. v. [read post]
9 Jul 2017, 1:11 am by Mark Summerfield
  One further step in that direction was taken by the Canadian Supreme Court on 30 June 2017, when it banished the so-called ‘Promise Doctrine’ of inutility from Canadian patent law: AstraZeneca Canada Inc v Apotex Inc 2017 SCC 36. [read post]
6 Jul 2017, 8:21 am by Steve Brachmann
Apotex Inc., which gives patent owners a far greater ability to protect their intellectual property in the face of Canada’s Promise Doctrine, a part of Canadian patent law that requires an invention to be “useful” in order to be patent-eligible subject matter. [read post]